Printer Friendly
The Free Library
14,716,402 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Hybrid particle mimics AIDS virus.


Hybrid particle mimics AIDS virus AIDS virus
n.
See HIV.
 

By exploiting peripatetic pieces of yeast's genetic material called retrotransposons, British scientists are hoping to hasten the development of effective AIDS vaccines. "Transposable transposable /trans·pos·a·ble/ (trans-poz´ah-b'l) capable of being interchanged or put in a different place or order.  elements'--DNA segments that readily move from one location on a chromosome to another--were first discovered in maize maize: see corn.  more than 30 years ago, and later in fruit flies and bacteria. When researchers found several years ago that these restless chunks of DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 can transfer traits like antibiotic resistance antibiotic resistance,
n the ability of certain strains of microorganisms to develop resistance to antibiotics.

antibiotic resistance 
 between bacteria, they began using them as carriers of foreign DNA in genetic experiments (SN: 10/23/82, p.260).

Scientists at the Oxford-based British Bio-technology Ltd., the University of Oxford and the University of Kent in Canterbury used similar technology in their experiments with yeast retrotransposons, reported in the Spet. 3 NATURE. The retrotransposons code for a group of yeast proteins that assemble themselves into harmless "virus-like particles'--which the researchers have tricked into accepting segments from the HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  viruses causing AIDS.

These hybrid faux-virus particles may be useful in developing both AIDS vaccines and diagnostic tests to detect the HIV viruses, say the scientists. Oxford's Susan M. Kingsman told SCIENCE NEWS that 100 copies of the HIV segments can be incorporated into each "ball of protein' that forms the custom-made particles. The presence of so many repeated units of HIV antigen is likely to elicit better immunity when injected into an animal, she says. Yet-unpublished work by the British researchers suggests that a wide range of proteins, including those from viruses other than HIV, could be inserted into the retrotransposons, says Kingsman.

Noting that the hybrid particles are simple to construct and then purify Purify - A debugging tool from Pure Software. , the authors also report that rabbits injected with the recombinant particles develop antibodies against the HIV component of the particles, suggesting a "new approach to vaccine production.'
COPYRIGHT 1987 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1987, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Author:Edwards, Diane D.
Publication:Science News
Date:Sep 5, 1987
Words:297
Previous Article:First test-firing for redesigned shuttle booster rocket.
Next Article:Plastic shocks and visible sparks. (research on electrostatic hazards)
Topics:



Related Articles
AIDS vaccine: research on target.
AIDS virus in bone, vaccine on trial.
Finding protection in AIDS virus fragments.
AIDS: long research road still looms ahead.
AIDS vaccine: safe, but does it work?
One-two punch for AIDS prevention. (AIDS vaccine)
Two steps forward in AIDS vaccine search. (finding new animal species and developing new vaccine for research)
Two strides toward a workable AIDS vaccine. (crippled live virus may protect monkeys from simian AIDS and virus of AIDS picks up bits of infected...
Development of a mouse model for HIV/AIDS.(Presentations)
HIV vaccines: the future looks promising.(Perspectives)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles